Skip to main content
. 2018 Jul 23;8:11045. doi: 10.1038/s41598-018-29396-5

Figure 2.

Figure 2

Identification of FGF21 interacting sites on β-Klotho by solid-phase binding assay. (A,B) Binding of β-Klotho in WT CM to (A) FGF21 and (B) 39F7, an anti-β-Klotho antibody, measured by solid-phase binding assay. Results are normalized to the response at the highest concentration of the biotinylated proteins. The curves and EC50 values are mean ± SD of at least 3 independent experiments performed in duplicates. (C,D) EC50 values determined from the solid-phase binding assay between β-Klotho and FGF21 for (C) alanine and (D) arginine mutants. EC50 values are expressed as fold change relative to WT CM. *Binding curve did not converge.